In a recent study, involving a multiethnic population of 424 patients, CK-18 fragments levels showed a high specificity for NAFLD and fibrosis but a limited sensitivity/specificity for NASH (58%/68%) [35]. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatotic liver disease.